Industry Updates & UBC News

UBC - December 21, 2012
NPS Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Gattex® (Teduglutide [rDNA origin]) for Injection, for subcutaneous use for the treatment of adult patients with short bowel syndrome (...
UBC Pharma News - November 28, 2012
The Express Scripts Drug Trend Report was the first of its kind when initially published in 1997.  This year, by transitioning the report to a quarterly publication, Drug Trend Quarterly, Express Scripts is providing more timely...
UBC Pharma News - November 05, 2012
During ISPOR’s 15th Annual European Congress, held in Berlin, Germany, November 3-7, 2012, UBC will have a strong presence and an influential voice.  ISPOR, the International Society for Pharmacoeconomics and Outcomes Research,...
HealthBridge Pharma & Biotech - October 08, 2012
Express Scripts is in the news!  Today, Vivus, Inc., announced that Express Scripts has joined the Qsymia™ Certified Home Delivery Pharmacy Network.   Qsymia is the first FDA-approved once daily combination therapy for...
, Vice President, Global Pharmaceutical Business Development - October 04, 2012
The  Pharma Outcomes conference, held in St. Louis, Missouri, last month, was a great opportunity to meet with pharma manufacturers and talk about how we here at Express Scripts and UBC can help products launch and maintain a...

Pages